Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011

BETHESDA, Md., August 9, 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: CHDX), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the second quarter and first half of 2011 ended June 30, 2011.

Second Quarter 2011 Financial Highlights

• Revenue from healthcare services increased 19.4% to $29.5 million from $24.7 million in the prior year period.
• Income from operations was $3.4 million compared to $1.9 million in the prior year period.
• Net income was $2.9 million, or $0.17 per diluted share, compared to net income of $0.84 million, or $0.06 per diluted share, in the prior year period.
• Adjusted EBITDA was $6.0 million, compared to adjusted EBITDA of $4.4 million in the prior year period.
• Development, pre-opening and start-up expense was $1.2 million compared to $388,000 in the prior year period.

Roberta Lipson, President and CEO of Chindex, commented, "Second quarter financial performance reflects continued revenue growth driven by steady inpatient and outpatient demand across our network. Our operating results were also favorable this quarter with strong improvements in net income and adjusted EBITDA on a year over year basis. Additionally, we remain optimistic that our goals for capacity build-out are nicely aligned with the favorable environment for the growth of private healthcare in China. We are on-track with the phased opening of our Beijing UFH hospital expansion and we continue to expect completion of the project by the end of the year."

Second Quarter 2011 Financial Results

Second quarter 2011 revenue from healthcare services increased 19.4% to $29.5 million from $24.7 million in the prior year period, reflecting growing inpatient and outpatient volume across the United Family Healthcare network. Outpatient services contributed 59% of revenue and inpatient services contributed 41% of revenue in the second quarter of 2011, in line with the prior year period. By service line, surgical services contributed 18.1%, OB/GYN contributed 14.1%, pediatrics contributed 8.4%, ancillary services contributed 32.6% and other services contributed 26.8% of revenue.

Operating expenses for the three months ended June 30, 2011 increased to $26.1 million from $21.7 million in the prior year period. Development, pre-opening and start up expenses were $1.2 million this quarter including expenses for the Beijing United expansion, development expenses for the Tianjin United project and lease expense for the United Family Rehabilitation Hospital in Beijing.

Operating expenses also included certain non-cash expenses including $466,000 of stock compensation expense compared to $664,000 for the prior year period. Due to the change in business organization the Company also incurred an increase in corporate overhead costs of approximately $325,000 per quarter compared to the prior year period. As previously disclosed, moving forward, these corporate overhead expenses previously shared with the medical products division will continue to be recognized by the Company.

Adjusted EBITDA in the second quarter of 2011 increased to approximately $6.0 million compared to $4.4 million in the prior year period.

Income from operations was $3.4 million compared to income from operations of $1.9 million in the prior year period.

The Company recorded a $1.3 million provision for taxes in the second quarter of 2011 compared to a provision for taxes of $1.0 million in the prior year period.

Net income for the quarter ended June 30, 2011 was $2.9 million, or $0.17 per diluted share, compared to $836,000, or $0.06 per diluted share, in the prior year period. For the second quarter of 2011, weighted average diluted shares outstanding were 17.5 million.

As of June 30, 2011, the Company had $77.3 million in cash and cash equivalents and investments.

First Half 2011 Financial Results

During the first half of 2011, revenue from healthcare services increased 17.0% to $53.7 million from $45.9 million in the prior year period, reflecting growing inpatient and outpatient volume across the United Family Healthcare network. Outpatient services contributed 60% of revenue and inpatient services contributed 40% of revenue in the first half of 2011 compared to 59% and 41%, respectively, in the year ago period. By service line, surgical services contributed 18.0%, OB/GYN contributed 14.5%, pediatrics contributed 8.0%, ancillary services contributed 33.0% and other services contributed 26.5% of revenue.

Operating expenses for the first half of 2011 increased 21.6% to $50.6 million from $41.6 million in the prior year period. Development, pre-opening and start up expenses rose to $2.0 million from $801,000 in the prior year period primarily as a result of expenses related to the Company's Beijing, Pudong and Tianjin projects. Operating expenses also included certain non-cash expenses including $1.7 million of non-cash stock compensation expense and increased corporate cost allocations of approximately $650,000 due to the change in business organization when compared to the prior year. Income from operations was $3.1 million compared to income from operations of $3.0 million in the prior year period. Adjusted EBITDA was approximately $8.4 million compared to $6.9 million in the prior year period.

Provision for taxes was $2.1 million compared to $1.8 million in the prior year period. Net income was $1.7 million, or $0.11 per diluted share, compared to net income of $1.4 million, or $0.09 per diluted share, in the prior year period. For the first half of 2011 ended June 30, 2011, weighted average diluted shares outstanding were 17.4 million.

Non-GAAP Measures

The Company presents Adjusted EBITDA to better illustrate ongoing operational results. Adjusted EBITDA is defined as income (loss) before interest expense, income taxes, depreciation and amortization, and also excludes development, pre-opening and start-up expenses related to new and pending hospitals and clinics, equity in earnings (loss) income of unconsolidated affiliate, non-recurring charges for Chindex Medical Limited (CML) joint venture formation and effect of change in corporate cost allocations. The Company anticipates recurring development, pre-opening and start-up expense and notes that such expense is a basic element of the long term growth plan. Management believes that providing an Adjusted EBIDTA analysis to investors is a helpful metric to better illustrate the Company's operations, including development plans, and changes in presentation from historical periods. The Company uses Adjusted EBITDA for business planning and other purposes. Other companies may calculate Adjusted EBITDA differently, and therefore Chindex's Adjusted EBITDA may not be comparable to similarly titled measures of other companies. Adjusted EBITDA is not a measure of financial performance under U.S. generally accepted accounting principles (GAAP), and should not be considered in isolation or as an alternative to net income (loss), cash flows from operating activities and other measures determined in accordance with GAAP. Items excluded from Adjusted EBITDA are significant and necessary components to the operations of the Company's business, and, therefore, Adjusted EBITDA should only be used as a supplemental measure of operating performance.

Chindex Medical Limited

The Chindex Medical Limited joint venture (CML) between FosunPharma and Chindex International began operations on January 1, 2011. The strategic venture merged the former Medical Products division of Chindex International and select medical device companies of FosunPharma. FosunPharma owns 51% and Chindex owns 49% of the CML joint venture. Chindex recognizes its 49% interest in CML's net income using the equity method of accounting.

Accordingly, in the second quarter of 2011, other income and expenses includes $729,000 of income for Chindex's 49% share of CML. In recognizing its 49% interest in the net income of CML for the quarter, Chindex also included additional expenses for amortization of certain fair value adjustments made in connection with the formation of the joint venture.

Conference Call

Management will host a conference call at 8:00 am ET on August 9, 2011, to discuss financial results. To participate in the conference call, U.S. domestic callers may dial 1-877-303-9231 and international callers may dial 1-760-666-3567 approximately 10 minutes before the conference call is scheduled to begin. A telephone replay will be available from the day of the call until August 16, 2011, by dialing (U.S. domestic) 1-855-859-2056 or (international) 1-404-537-3406, passcode 86670003. A webcast of the earnings call will be accessible via Chindex's website at http://ir.chindex.com/events.cfm.

About Chindex International, Inc.

Chindex is an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare currently operates in Beijing, Shanghai and Guangzhou. The Company also provides medical capital equipment and products through Chindex Medical Ltd., a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. With thirty years of experience, the Company's strategy is to continue its growth as a leading integrated health care provider in the Greater China region. Further company information may be found at the Company's website at http://www.chindex.com.

Safe Harbor Statement

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in the Company's Transition Report on Form 10-K for the nine months ended December 31, 2010, updates and additions to those "Risk Factors" in the Company's interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or similar terms or the negative of these terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements.

- Financial Summary Attached -